chr2-99831464-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001386135.1(AFF3):c.921+6013A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0345 in 152,282 control chromosomes in the GnomAD database, including 141 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.034 ( 141 hom., cov: 33)
Consequence
AFF3
NM_001386135.1 intron
NM_001386135.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.39
Publications
3 publications found
Genes affected
AFF3 (HGNC:6473): (ALF transcription elongation factor 3) This gene encodes a tissue-restricted nuclear transcriptional activator that is preferentially expressed in lymphoid tissue. Isolation of this protein initially defined a highly conserved LAF4/MLLT2 gene family of nuclear transcription factors that may function in lymphoid development and oncogenesis. In some ALL patients, this gene has been found fused to the gene for MLL. Multiple alternatively spliced transcript variants that encode different proteins have been found for this gene. [provided by RefSeq, Jul 2008]
AFF3 Gene-Disease associations (from GenCC):
- KINSSHIP syndromeInheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- intellectual disabilityInheritance: AD Classification: MODERATE Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0601 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AFF3 | NM_001386135.1 | c.921+6013A>G | intron_variant | Intron 8 of 24 | ENST00000672756.2 | NP_001373064.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0345 AC: 5247AN: 152164Hom.: 141 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
5247
AN:
152164
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0345 AC: 5251AN: 152282Hom.: 141 Cov.: 33 AF XY: 0.0362 AC XY: 2697AN XY: 74460 show subpopulations
GnomAD4 genome
AF:
AC:
5251
AN:
152282
Hom.:
Cov.:
33
AF XY:
AC XY:
2697
AN XY:
74460
show subpopulations
African (AFR)
AF:
AC:
402
AN:
41576
American (AMR)
AF:
AC:
970
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
53
AN:
3472
East Asian (EAS)
AF:
AC:
329
AN:
5182
South Asian (SAS)
AF:
AC:
292
AN:
4824
European-Finnish (FIN)
AF:
AC:
486
AN:
10602
Middle Eastern (MID)
AF:
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2593
AN:
68018
Other (OTH)
AF:
AC:
79
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
259
517
776
1034
1293
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
220
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.